Drawing for STARSIL HEMOSTAT

USPTO serial 79120558

STARSIL HEMOSTAT

Reviewed by CopyMark Law Group

Reg. 4416442Status 404
Filing date
Status date
Registration date
Oct 15, 2013
Examiner
DOMBROW, COLLEEN M
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with STARSIL HEMOSTAT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bryan W. Bockhop

Bryan W. Bockhop Bockhop Intellectual Property Law, LLC2375 Mossy Branch DriveSnellville, GA 30078UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Chemical preparations for medical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade after surgical procedure and emergency treatments; chemical preparations for pharmaceutical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade after surgical procedure and emergency treatments; chemical preparations for veterinary purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade after surgical procedure and emergency treatments; chemico-pharmaceutical preparations for improving blood coagulation and supporting natural blood cascade; surgical tissues; pharmaceutical preparations, namely, haemostatic agents, blood clotting agents, and blood clotting powder; adhesive bandages with blood clotting properties; pharmaceutical preparations for the treatment of infectious diseases; medical plasters; bandage materials, namely, gauze and medical adhesive tape; bandage fabrics, namely, gauze; resorbing bandage materials, namely, gauze and medical adhesive tape; blood clotting resorbing bandage materials, namely, gauze and medical adhesive tapeSECTION 71 - CANCELLED—
010Surgical instruments and apparatus; medical instruments and apparatus for treating all kinds of bleedings; dental instruments and apparatus for treating all kind of dental bleedings; orthopedic device for treating bleeding during orthopedic procedures; surgical stitches, namely, wound closure devices; blood clotting surgical sponge; surgical implants comprising artificial material with a blood clotting coating; blood clotting coated surgical implants from artificial materialsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 10, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Dec 10, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 6, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Oct 12, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Oct 12, 2022INPCINVALIDATION PROCESSED—
Sep 30, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 1, 2022NC71NOTICE OF CANCELLATION SEC. 71 E-MAILED—
Jan 31, 2022C71TCANCELLED SECTION 71—
Jul 20, 2021PR71POST REGISTRATION ACTION MAILED - SEC.71—
Jul 3, 2020EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jan 3, 2020PR71POST REGISTRATION ACTION MAILED - SEC.71—
Nov 25, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 15, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 15, 2019ES71TEAS SECTION 71 RECEIVED—
Oct 15, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 9, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 2, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 15, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 15, 2014FIMPFINAL DISPOSITION PROCESSED—
Jan 15, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 15, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 30, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 30, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 10, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 27, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 25, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 25, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Jun 25, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 25, 2013GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 25, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 10, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 10, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 4, 2013ALIEASSIGNED TO LIE—
May 30, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 2, 2013RFNTREFUSAL PROCESSED BY IB—
Dec 6, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 6, 2012RFRRREFUSAL PROCESSED BY MPU—
Dec 6, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 5, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 4, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 29, 2012DOCKASSIGNED TO EXAMINER—
Nov 29, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 22, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance